Hans L. Tillmann

Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.

M. Manns, H. Tillmann, P. Flemming, 1999, Transplantation.

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.

M. Manns, J. Klempnauer, C. Trautwein, 2001, Journal of hepatology.

Quality of life in patients with various liver diseases

H. Tillmann, J. Mössner, K. Weissenborn, 2011, Journal of viral hepatitis.